Cargando…

Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles

Background: The need for endocrine monitoring in artificial cycles for frozen embryo transfer (FET) remains unclear and, more specifically, the value of the late-proliferative phase serum estradiol (E2) levels is with conflicting evidence in current literature. Objective: To investigate whether arti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackens, Shari, Santos-Ribeiro, Samuel, Orinx, Ellen, De Munck, Neelke, Racca, Annalisa, Roelens, Caroline, Popovic-Todorovic, Biljana, De Vos, Michel, Tournaye, Herman, Blockeel, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204383/
https://www.ncbi.nlm.nih.gov/pubmed/32425886
http://dx.doi.org/10.3389/fendo.2020.00255
_version_ 1783530054739820544
author Mackens, Shari
Santos-Ribeiro, Samuel
Orinx, Ellen
De Munck, Neelke
Racca, Annalisa
Roelens, Caroline
Popovic-Todorovic, Biljana
De Vos, Michel
Tournaye, Herman
Blockeel, Christophe
author_facet Mackens, Shari
Santos-Ribeiro, Samuel
Orinx, Ellen
De Munck, Neelke
Racca, Annalisa
Roelens, Caroline
Popovic-Todorovic, Biljana
De Vos, Michel
Tournaye, Herman
Blockeel, Christophe
author_sort Mackens, Shari
collection PubMed
description Background: The need for endocrine monitoring in artificial cycles for frozen embryo transfer (FET) remains unclear and, more specifically, the value of the late-proliferative phase serum estradiol (E2) levels is with conflicting evidence in current literature. Objective: To investigate whether artificial FET cycles require endocrine monitoring for the serum E2 level prior to initiation of exogenous progesterone administration after an endometrial thickness of 6.5 mm has been reached. Design: One thousand two hundred and twenty-two (n = 1,222) artificial FETs performed in a tertiary center between 2010 and 2015 were subdivided into 3 groups according to the following late-proliferative serum E2 level percentiles: ≤p10 (E2 ≤144 pg/ml; n = 124), p11–p90 (E2 from 145 to 438 pg/ml; n = 977) and >p90 (E2 >439 pg/ml; n = 121). A mixed-effects multilevel multivariable regression analysis was performed to assess the potential effect of the late-proliferative E2 level on the live birth rate (LBR). Results: The level of late-proliferative circulating E2 showed no significant difference in terms of LBR after FET. Specifically, the multivariable regression model demonstrated a LBR of 19.5% for the p11–p90 reference group, compared to 24.4% for the ≤p10 (p = 0.251) and 19.5% for the >p90 group (p = 0.989). Conclusion: In this large retrospective dataset, no association was observed between late-proliferative phase serum E2 levels and LBR following FET in artificially prepared cycles. Although, caution is warranted due to the retrospective nature of the analysis and the potential for unmeasured confounding, we argue that monitoring of the late-proliferative serum E2 levels and using them to guide clinical decision-making (e.g., medication step-up, cycle prolongation or cancelation) may be of questionable value.
format Online
Article
Text
id pubmed-7204383
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72043832020-05-18 Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles Mackens, Shari Santos-Ribeiro, Samuel Orinx, Ellen De Munck, Neelke Racca, Annalisa Roelens, Caroline Popovic-Todorovic, Biljana De Vos, Michel Tournaye, Herman Blockeel, Christophe Front Endocrinol (Lausanne) Endocrinology Background: The need for endocrine monitoring in artificial cycles for frozen embryo transfer (FET) remains unclear and, more specifically, the value of the late-proliferative phase serum estradiol (E2) levels is with conflicting evidence in current literature. Objective: To investigate whether artificial FET cycles require endocrine monitoring for the serum E2 level prior to initiation of exogenous progesterone administration after an endometrial thickness of 6.5 mm has been reached. Design: One thousand two hundred and twenty-two (n = 1,222) artificial FETs performed in a tertiary center between 2010 and 2015 were subdivided into 3 groups according to the following late-proliferative serum E2 level percentiles: ≤p10 (E2 ≤144 pg/ml; n = 124), p11–p90 (E2 from 145 to 438 pg/ml; n = 977) and >p90 (E2 >439 pg/ml; n = 121). A mixed-effects multilevel multivariable regression analysis was performed to assess the potential effect of the late-proliferative E2 level on the live birth rate (LBR). Results: The level of late-proliferative circulating E2 showed no significant difference in terms of LBR after FET. Specifically, the multivariable regression model demonstrated a LBR of 19.5% for the p11–p90 reference group, compared to 24.4% for the ≤p10 (p = 0.251) and 19.5% for the >p90 group (p = 0.989). Conclusion: In this large retrospective dataset, no association was observed between late-proliferative phase serum E2 levels and LBR following FET in artificially prepared cycles. Although, caution is warranted due to the retrospective nature of the analysis and the potential for unmeasured confounding, we argue that monitoring of the late-proliferative serum E2 levels and using them to guide clinical decision-making (e.g., medication step-up, cycle prolongation or cancelation) may be of questionable value. Frontiers Media S.A. 2020-04-30 /pmc/articles/PMC7204383/ /pubmed/32425886 http://dx.doi.org/10.3389/fendo.2020.00255 Text en Copyright © 2020 Mackens, Santos-Ribeiro, Orinx, De Munck, Racca, Roelens, Popovic-Todorovic, De Vos, Tournaye and Blockeel. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Mackens, Shari
Santos-Ribeiro, Samuel
Orinx, Ellen
De Munck, Neelke
Racca, Annalisa
Roelens, Caroline
Popovic-Todorovic, Biljana
De Vos, Michel
Tournaye, Herman
Blockeel, Christophe
Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
title Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
title_full Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
title_fullStr Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
title_full_unstemmed Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
title_short Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer Cycles
title_sort impact of serum estradiol levels prior to progesterone administration in artificially prepared frozen embryo transfer cycles
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204383/
https://www.ncbi.nlm.nih.gov/pubmed/32425886
http://dx.doi.org/10.3389/fendo.2020.00255
work_keys_str_mv AT mackensshari impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT santosribeirosamuel impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT orinxellen impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT demunckneelke impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT raccaannalisa impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT roelenscaroline impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT popovictodorovicbiljana impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT devosmichel impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT tournayeherman impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles
AT blockeelchristophe impactofserumestradiollevelspriortoprogesteroneadministrationinartificiallypreparedfrozenembryotransfercycles